Daniel Lynch, Director at Blueprint Medicines Corp (BPMC), sold 12,500 shares at $80.42 ($1.0M) on 2018-02-14, disclosed to the SEC on 2018-02-16.
Open-market sale of $1.0M BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SWTX | SELL | 2025-02-12 | $15.4M | — | Filing → |
| BPMC | SELL | 2018-02-14 | $2.6M | — | Filing → |
| BPMC | SELL | 2017-11-17 | $420K | — | Filing → |